Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8508447 | Actualités Pharmaceutiques | 2018 | 4 Pages |
Abstract
Diagnosis, initiation of treatment, treatment switching and high-risk periods are key moments in the support of patients with multiple sclerosis. Throughout their treatment, patients express numerous expectations with regard to pharmacists, which requires closer collaboration between health professionals and the development of new areas of activity for pharmacists.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Laetitia (Docteur en pharmacie, maître de conférences associé),